GS-US-321-0102: A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, Monoclonal

Printer-friendly versionSend by emailPDF version

Name

Gilead Sciences, Incorporated

Anticipated Amount

255 057.00

Activity Type

Clinical Trial

Award Type

Contract

Date

August 1, 2012 to August 30, 2014

Award Number

006283-00001

Sponsor Award Number

GS-US-321-0102

Award Contacts

Name

Boyer,Thomas D

Title

Principal Investigator

Unit

Liver Research Institute

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona